Precision medicine in allergic disease—food allergy, drug allergy, and anaphylaxis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology

Antonella Muraro; Robert F Lemanske; Mariana Castells; Maria J Torres; David Khan; Hans-Uwe Simon; Carsten Bindslev-Jensen; Wesley Burks; Lars K Poulsen; Hugh A Sampson; Margitta Worm; Kari C Nadeau

doi:10.1111/all.13132

Precision medicine in allergic disease—food allergy, drug allergy, and anaphylaxis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology

Antonella Muraro, Robert F Lemanske, Mariana Castells, Maria J Torres, David Khan, Hans-Uwe Simon, Carsten Bindslev-Jensen, Wesley Burks, Lars K Poulsen, Hugh A Sampson, Margitta Worm, Kari C Nadeau

Institut for Klinisk Medicin

86 Citationer (Scopus)

Abstract

This consensus document summarizes the current knowledge on the potential for precision medicine in food allergy, drug allergy, and anaphylaxis under the auspices of the PRACTALL collaboration platform. PRACTALL is a joint effort of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology, which aims to synchronize the European and American approaches to allergy care. Precision medicine is an emerging approach for disease treatment based on disease endotypes, which are phenotypic subclasses associated with specific mechanisms underlying the disease. Although significant progress has been made in defining endotypes for asthma, definitions of endotypes for food and drug allergy or for anaphylaxis lag behind. Progress has been made in discovery of biomarkers to guide a precision medicine approach to treatment of food and drug allergy, but further validation and quantification of these biomarkers are needed to allow their translation into practice in the clinical management of allergic disease.

Originalsprog	Engelsk
Tidsskrift	Allergy
Vol/bind	72
Udgave nummer	7
Sider (fra-til)	1006-1021
Antal sider	16
ISSN	0105-4538
DOI	https://doi.org/10.1111/all.13132
Status	Udgivet - jul. 2017

Adgang til dokumentet

10.1111/all.13132

all.13132Forlagets udgivne version, 576 KB

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.13132

Fingeraftryk

Dyk ned i forskningsemnerne om 'Precision medicine in allergic disease—food allergy, drug allergy, and anaphylaxis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Muraro, A., Lemanske, R. F., Castells, M., Torres, M. J., Khan, D., Simon, H-U., Bindslev-Jensen, C., Burks, W., Poulsen, L. K., Sampson, H. A., Worm, M., & Nadeau, K. C. (2017). Precision medicine in allergic disease—food allergy, drug allergy, and anaphylaxis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology. Allergy, 72(7), 1006-1021. https://doi.org/10.1111/all.13132

Precision medicine in allergic disease—food allergy, drug allergy, and anaphylaxis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology. / Muraro, Antonella; Lemanske, Robert F; Castells, Mariana et al.

I: Allergy, Bind 72, Nr. 7, 07.2017, s. 1006-1021.

Publikation: Bidrag til tidsskrift › Review › peer review

Muraro, A, Lemanske, RF, Castells, M, Torres, MJ, Khan, D, Simon, H-U, Bindslev-Jensen, C, Burks, W, Poulsen, LK, Sampson, HA, Worm, M & Nadeau, KC 2017, 'Precision medicine in allergic disease—food allergy, drug allergy, and anaphylaxis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology', Allergy, bind 72, nr. 7, s. 1006-1021. https://doi.org/10.1111/all.13132

@article{82b12c2c89eb4fac9385e5d898d49f20,

title = "Precision medicine in allergic disease—food allergy, drug allergy, and anaphylaxis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology",

abstract = "This consensus document summarizes the current knowledge on the potential for precision medicine in food allergy, drug allergy, and anaphylaxis under the auspices of the PRACTALL collaboration platform. PRACTALL is a joint effort of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology, which aims to synchronize the European and American approaches to allergy care. Precision medicine is an emerging approach for disease treatment based on disease endotypes, which are phenotypic subclasses associated with specific mechanisms underlying the disease. Although significant progress has been made in defining endotypes for asthma, definitions of endotypes for food and drug allergy or for anaphylaxis lag behind. Progress has been made in discovery of biomarkers to guide a precision medicine approach to treatment of food and drug allergy, but further validation and quantification of these biomarkers are needed to allow their translation into practice in the clinical management of allergic disease.",

author = "Antonella Muraro and Lemanske, {Robert F} and Mariana Castells and Torres, {Maria J} and David Khan and Hans-Uwe Simon and Carsten Bindslev-Jensen and Wesley Burks and Poulsen, {Lars K} and Sampson, {Hugh A} and Margitta Worm and Nadeau, {Kari C}",

year = "2017",

month = jul,

doi = "10.1111/all.13132",

language = "English",

volume = "72",

pages = "1006--1021",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley Online",

number = "7",

}

TY - JOUR

T1 - Precision medicine in allergic disease—food allergy, drug allergy, and anaphylaxis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology

AU - Muraro, Antonella

AU - Lemanske, Robert F

AU - Castells, Mariana

AU - Torres, Maria J

AU - Khan, David

AU - Simon, Hans-Uwe

AU - Bindslev-Jensen, Carsten

AU - Burks, Wesley

AU - Poulsen, Lars K

AU - Sampson, Hugh A

AU - Worm, Margitta

AU - Nadeau, Kari C

PY - 2017/7

Y1 - 2017/7

N2 - This consensus document summarizes the current knowledge on the potential for precision medicine in food allergy, drug allergy, and anaphylaxis under the auspices of the PRACTALL collaboration platform. PRACTALL is a joint effort of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology, which aims to synchronize the European and American approaches to allergy care. Precision medicine is an emerging approach for disease treatment based on disease endotypes, which are phenotypic subclasses associated with specific mechanisms underlying the disease. Although significant progress has been made in defining endotypes for asthma, definitions of endotypes for food and drug allergy or for anaphylaxis lag behind. Progress has been made in discovery of biomarkers to guide a precision medicine approach to treatment of food and drug allergy, but further validation and quantification of these biomarkers are needed to allow their translation into practice in the clinical management of allergic disease.

AB - This consensus document summarizes the current knowledge on the potential for precision medicine in food allergy, drug allergy, and anaphylaxis under the auspices of the PRACTALL collaboration platform. PRACTALL is a joint effort of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology, which aims to synchronize the European and American approaches to allergy care. Precision medicine is an emerging approach for disease treatment based on disease endotypes, which are phenotypic subclasses associated with specific mechanisms underlying the disease. Although significant progress has been made in defining endotypes for asthma, definitions of endotypes for food and drug allergy or for anaphylaxis lag behind. Progress has been made in discovery of biomarkers to guide a precision medicine approach to treatment of food and drug allergy, but further validation and quantification of these biomarkers are needed to allow their translation into practice in the clinical management of allergic disease.

U2 - 10.1111/all.13132

DO - 10.1111/all.13132

M3 - Review

C2 - 28122115

SN - 0105-4538

VL - 72

SP - 1006

EP - 1021

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 7

ER -